Vanberra Signal
Free trial

Enterome

Curated by Signal

Developer of immunomodulators for cancer and auto-immune diseases

Health Technologyenterome.com

Overview

Developer of immunomodulators for cancer and auto-immune diseases. The company develops drugs based on the ability to de-code the gut microbiome’s interaction with the immune system. The company has developed two technology platforms which include OncoMimics therapeutic cancer vaccines, and EndoMimics an oral bioactive to treat inflammatory and autoimmune diseases.

Key facts

Founded
2008
Headquarters
Paris, France
Stage
Sign up to view
Industry
Health Technology

Business model

3 products and services
Sign up to view

Contact

Primary office
Sign up to view
Email
Sign up to view
Phone
Sign up to view

More on Vanberra Signal

Members only
Business overviewCore metrics and financialsPeopleLeadership and key peopleSimilar companiesPeers and competitorsDeep AnalysisAI-generated strategic report

Competitors & similar companies

More Health Technology companies

  • Goalmap

    Provider of employee wellness platform

    Health TechnologyAix en provence, France

  • REEV

    Provider of robotic orthosis for walking assistance

    Health TechnologyToulouse, France

  • Solence

    Provider of a companion app for women to help alleviate symptoms of PCOS

    Health TechnologyStrasbourg, France

About Enterome

What does Enterome do?

Developer of immunomodulators for cancer and auto-immune diseases.

Where is Enterome headquartered?

Enterome is headquartered in Paris, France.

When was Enterome founded?

Enterome was founded in 2008.

Which sector is Enterome in?

Enterome operates in Health Technology.

Who are Enterome's competitors?

Companies similar to Enterome include Goalmap, REEV, and Solence.